DDX5 and hepatocellular carcinoma: We found that HCCs with low DDX5 mRNA exhibited higher GPX4 mRNA compared to HCCs with high DDX5 expression (Fig. 4H), and importantly, elevated GPX4 mRNA levels were associated with poor survival outcomes in sorafenib-treated HCC patients (Fig. 4I).